These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8743280)
21. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. Rosen CJ; Chesnut CH; Mallinak NJ J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404 [TBL] [Abstract][Full Text] [Related]
22. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study. Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806 [TBL] [Abstract][Full Text] [Related]
23. Effect of an oral calcium load on urinary markers of collagen breakdown. Rubinacci A; Divieti P; Polo RM; Zampino M; Resmini G; Tenni R J Endocrinol Invest; 1996 Dec; 19(11):719-26. PubMed ID: 9061504 [TBL] [Abstract][Full Text] [Related]
24. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study. Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321 [TBL] [Abstract][Full Text] [Related]
25. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone. Sinigaglia L; Varenna M; Binelli L; Beltrametti P; Zucchi F; Arrigoni M; Frignani S; Abbiati G Calcif Tissue Int; 1997 Oct; 61(4):279-84. PubMed ID: 9312197 [TBL] [Abstract][Full Text] [Related]
26. The short-term effects of conjugated estrogen on bone turnover in older women. Prestwood KM; Pilbeam CC; Burleson JA; Woodiel FN; Delmas PD; Deftos LJ; Raisz LG J Clin Endocrinol Metab; 1994 Aug; 79(2):366-71. PubMed ID: 8045949 [TBL] [Abstract][Full Text] [Related]
27. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. Eastell R; Colwell A; Hampton L; Reeve J J Bone Miner Res; 1997 Jan; 12(1):59-65. PubMed ID: 9240726 [TBL] [Abstract][Full Text] [Related]
28. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyridinium cross-links. Pardini DP; Sabino AT; Meneses AM; Kasamatsu T; Vieira JG Sao Paulo Med J; 2000 Jan; 118(1):3-6. PubMed ID: 10685120 [TBL] [Abstract][Full Text] [Related]
29. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. Hannon R; Blumsohn A; Naylor K; Eastell R J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076 [TBL] [Abstract][Full Text] [Related]
30. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase. Alexandersen P; Hassager C; Riis BJ Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181 [TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Uebelhart D; Gineyts E; Chapuy MC; Delmas PD Bone Miner; 1990 Jan; 8(1):87-96. PubMed ID: 2106358 [TBL] [Abstract][Full Text] [Related]
32. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Vural P; Akgul C; Canbaz M Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975 [TBL] [Abstract][Full Text] [Related]
33. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477 [TBL] [Abstract][Full Text] [Related]
34. Biological variability in assessing the clinical value of biochemical markers of bone turnover. Plebani M; Bernardi D; Meneghetti MF; Ujka F; Zaninotto M Clin Chim Acta; 2000 Sep; 299(1-2):77-86. PubMed ID: 10900294 [TBL] [Abstract][Full Text] [Related]
35. Effects of low phosphate intake on bone and mineral metabolism in rats: evaluation by biochemical markers and pyridinium cross-link formation in bone. Hoshino H; Kushida K; Takahashi M; Koyama S; Yamauchi H; Inoue T Ann Nutr Metab; 1998; 42(2):110-8. PubMed ID: 9625281 [TBL] [Abstract][Full Text] [Related]
36. Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years. Leino A; Järvisalo J; Impivaara O; Kaitsaari M Calcif Tissue Int; 1994 Apr; 54(4):262-7. PubMed ID: 8062141 [TBL] [Abstract][Full Text] [Related]
37. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. Beardsworth LJ; Eyre DR; Dickson IR J Bone Miner Res; 1990 Jul; 5(7):671-6. PubMed ID: 2118710 [TBL] [Abstract][Full Text] [Related]
38. Markers of bone turnover in postmenopausal women receiving hormone replacement therapy. Hamwi A; Ganem AH; Grebe C; Kerschan-Schindl K; Preisinger E; Boschitsch E; Bieglmayer C Clin Chem Lab Med; 2001 May; 39(5):414-7. PubMed ID: 11434391 [TBL] [Abstract][Full Text] [Related]
39. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914 [TBL] [Abstract][Full Text] [Related]